Clinical Trial 44343

Long Beach, CA 90806


Summary:

The purpose of this study is to characterize the efficacy and safety of evobrutinib 45 mg administered orally twice daily versus teriflunomide (Aubagio®; 14 mg once a day orally) in participants with relapsing multiple sclerosis (RMS).


Qualified Participants Must:

• Be 18-55 years old
• Be diagnosed with RMS (relapsing-remitting multiple sclerosis [RRMS] or SPMS with relapses)
• One or more documented relapses within the 2 years before Screening
Additional criteria applies, please contact the site for full details.


Qualified Participants May Receive:

Compensation of up to $4,375 for time, complimentary transportation and meals, no cost study-related treatments and medications.


Available At:

Collaborative Neuroscience Research
2600 Redondo Ave 4th floor
Long Beach, CA 90806
View Clinic Location

 


If you or someone you care for is interested in participating and lives within 50 miles of the location shown, please complete the form below and click 'Submit'

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.